Navigation Links
Ovalum Ltd. Announces Success in Coronary Cases Using CiTop™ ExPander™ Guidewire
Date:7/11/2008

Following First-in-Man study success, Ovalum Ltd. launches a multicenter study using the CiTop™ technology in the coronary arteries. Ovalum Ltd., a privately held Israeli medical device company, has announced today successful experiences using CiTop™ ExPander™ Guidewire in traversing chronic total occlusions in the coronary arteries.

Rehovot , Israel (PRWEB) July 11, 2008 -- Following First-in-Man study success, Ovalum Ltd. launches a multicenter study using the CiTop™ technology in the coronary arteries.

Ovalum Ltd., a privately held Israeli medical device company, has announced today successful experiences using CiTop™ ExPander™ Guidewire in traversing chronic total occlusions in the coronary arteries.

Chronic Total Occlusion (CTO) is one of the main challenges that Interventional Cardiologists face today. Attempts in opening coronary CTOs by using mechanical wires are ranging from 26% to 85% and are operator dependent. In order to increase success rate and make it less operator-dependent, the CiTop™ ExPander™ Guidewire was designed. The CiTop™ ExPander™ Guidewire is a 0.014" Guidewire which combines conventional guidewire navigational properties with a tip dilation feature to aid in releasing a wedged guidewire and allow its advancement through difficult occlusions.

The company has completed successfully its First-in-Man study in the use of the CiTop™ ExPander™ Guidewire in the coronary arteries. Dr. Keyur H. Parikh, The Heart Care Clinic/Care Cardiovascular Consultants (Ahmedabad, India), Principle Investigator of the study has said: "Ovalum with its CiTop™ wire has discovered an approach to a safe and sure way to cross CTOs. Chronic Total Occlusions is one of the last frontiers of the Cardiologists, the CiTop™ wire has shown me an approach towards that last frontier.... "
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe
2. Ovalum Ltd. Received Clearance to Market the CiTop™ Product-Line in Israel
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2015)... July 24, 2015 Orexigen Therapeutics, Inc. (Nasdaq: ... for the second quarter 2015 on Thursday, August 6 ... provide a business update and discuss the financial results ... a.m. Eastern Time (5:00 a.m. Pacific Time). ... calling (800) 447-0521 (domestic) or (847) 413-3238 (international), participant ...
(Date:7/23/2015)... July 23, 2015 ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... results for the second quarter 2015 on Thursday, August 6, ... and webcast on that day at 5:00 pm ET to ... business update. The call will be hosted by Andrew ... , , , LIVE CALL: , , , ...
(Date:7/23/2015)... ... July 23, 2015 , ... July 23, ... providing more targeted treatment options with fewer side effects, according to Erik P. ... Cancer Center. , At the American Brain Tumor Association (ABTA) National Patient and ...
(Date:7/23/2015)... , July 23, 2015 /PRNewswire/ – Sigma-Aldrich Corporation ... high technology company, today announced the Company has received ... its Dekalb and ... Louis . The certification extends Sigma-Aldrich,s ability to ... proteins and antibodies used in diagnostic assays, and provides ...
Breaking Biology Technology:ImmunoCellular Therapeutics to Report Second Quarter 2015 Financial Results on August 6, 2015 2Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 2Radiation Oncology Advances Improve Safety and Efficacy of Treatment for Brain Tumors 3Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials 2Sigma-Aldrich Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials 3
... Signal Genetics, the parent company of Myeloma Health, ... oncology, today announced the formation of their Scientific Advisory ... Director, Jerome Lipper Multiple Myeloma Center, ... Medicine, Harvard Medical School Dr. Anderson of ...
... Calif., Oct. 26 Telik, Inc. (Nasdaq: ... company,s lead therapeutic product candidate, has been selected by ... Top 10 Most Interesting Oncology Projects to Watch."  Windhover ... executives in the pharmaceutical, biotechnology, and medical device industries. ...
... Regado Biosciences, a privately held company leading the development ... David J. Mazzo, PhD, President and CEO, will be ... Mazzo,s presentation will be given at the Waldorf-Astoria Hotel ... at 10:45 a.m. EDT in the Louis XVI Room. ...
Cached Biology Technology:Signal Genetics Announces Establishment of Scientific Advisory Board 2Signal Genetics Announces Establishment of Scientific Advisory Board 3TELINTRA® Named One of the 10 Most Interesting Oncology Projects to Watch 2TELINTRA® Named One of the 10 Most Interesting Oncology Projects to Watch 3Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City 2Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City 3
(Date:6/30/2015)... , June 30, 2015 To bolster its efforts ... HYPR Corp. announced today the addition of two new team ... as board advisor and David Raviv will act ... underscore HYPR Corp.,s commitment to providing the most secure solutions ... Sirota co-founded Layer 7 Technologies, a provider of security ...
(Date:6/25/2015)... , June 25, 2015  Imagine a tool specifically ... a healthier, happier life. That,s exactly what USANA,s ... do. The cutting-edge, portable health program provides a personalized ... to help improve your lifestyle and nutrition. ... and gala Wednesday night, USANA,s THA was honored with ...
(Date:6/24/2015)... 22, 2015 Research ... of the "Huawei Ascend Mate 7 Fingerprint ... their offering. Huawei,s technological choice for ... direction than Apple,s and Samsung,s one. The Ascend ... by Fingerprint Cards, a main actor in capacitive ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... Photosynthesis takes place in specialized membrane systems, made up ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich has now ... the edge of each stack. Scanning electron microscopy ... mays ) showing thylakoids (green) and assimilation starch granules ...
...  Polymer Technology Systems, Inc. (PTS, Inc.), the U.S.-based manufacturer ... products, has announced the issuance of two new U.S. ... of health data collected by point-of-care testing devices using ... a method and apparatus for manufacturing disposable dry test ...
... 2013 /PRNewswire-iReach/ -- Urologyweb.com, a leading website from Dr. ... outlining which prostate cancers really need treatment. ... favorable-risk Gleason 6 (3+3) prostate cancer and the ... not progress and do not need any treatment whether through ...
Cached Biology News:Photosynthesis: Membranes in tight corners 2PTS, Inc. Announces Two New Patents 2Which Prostate Cancers Really Need Treatment? 2Which Prostate Cancers Really Need Treatment? 3
Sphingosine 1-phosphate receptor Edg-1...
Bag-1 (K-20)...
... atoms at the 3, 3', 4, and ... as an internal standard for the quantification ... LC-mass spectrometry. PGE2 is one of the ... one of the most widely investigated prostaglandins. ...
, Glycerol 30%...
Biology Products: